Gibson Christopher

  Total Buys: 0
  Total Sales: 64
  Total Transaction Volume: $37.76M
Company Ticker Role Filing Date/Time (ET) Transaction Type Transaction Value Filing
RXRX Chief Executive Officer Nov 19, 2025 07:37 PM

Option Exercise

N/A

RXRX Chief Executive Officer Nov 19, 2025 07:37 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Nov 19, 2025 07:37 PM Sale

$166.4K

RXRX Chief Executive Officer Nov 6, 2025 04:23 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Nov 6, 2025 04:23 PM

Bona fide gift

N/A

RXRX Chief Executive Officer Nov 6, 2025 04:23 PM Sale

$208.4K

RXRX Chief Executive Officer Oct 24, 2025 06:49 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Oct 24, 2025 06:49 PM Sale

$570.0K

RXRX Chief Executive Officer Oct 10, 2025 06:03 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Oct 10, 2025 06:03 PM

Bona fide gift

N/A

RXRX Chief Executive Officer Oct 10, 2025 06:03 PM Sale

$604.0K

RXRX Chief Executive Officer Sep 26, 2025 06:32 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Sep 26, 2025 06:32 PM Sale

$476.0K

RXRX Chief Executive Officer Sep 12, 2025 04:24 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Sep 12, 2025 04:24 PM

Bona fide gift

N/A

RXRX Chief Executive Officer Sep 12, 2025 04:24 PM Sale

$471.0K

RXRX Chief Executive Officer Aug 28, 2025 08:00 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Aug 28, 2025 08:00 PM Sale

$484.0K

RXRX Chief Executive Officer Aug 19, 2025 06:22 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 13, 2025 09:03 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Aug 13, 2025 09:03 PM

Bona fide gift

N/A

RXRX Chief Executive Officer Aug 13, 2025 09:03 PM Sale

$3.26M

RXRX Chief Executive Officer May 19, 2025 04:44 PM

Option Exercise

N/A

RXRX Chief Executive Officer Mar 28, 2025 04:52 PM Sale

$836.99K

RXRX Chief Executive Officer Mar 7, 2025 04:16 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Mar 7, 2025 04:16 PM Sale

$259.0K

RXRX Chief Executive Officer Feb 20, 2025 04:42 PM

Option Exercise

N/A

RXRX Chief Executive Officer Feb 7, 2025 04:14 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Feb 7, 2025 04:14 PM Sale

$316.0K

RXRX Chief Executive Officer Feb 5, 2025 04:50 PM

Grant/Award

N/A

RXRX Chief Executive Officer Feb 5, 2025 04:50 PM

Option Exercise

N/A

RXRX Chief Executive Officer Jan 13, 2025 05:26 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Jan 13, 2025 05:26 PM Sale

$287.2K

RXRX Chief Executive Officer Dec 6, 2024 05:46 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Dec 6, 2024 05:46 PM Sale

$285.6K

RXRX Chief Executive Officer Nov 19, 2024 06:26 PM

Option Exercise

N/A

RXRX Chief Executive Officer Nov 15, 2024 06:52 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Nov 15, 2024 06:52 PM Sale

$301.8K

RXRX Chief Executive Officer Oct 4, 2024 06:30 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Oct 4, 2024 06:30 PM Sale

$244.8K

RXRX Chief Executive Officer Sep 6, 2024 04:57 PM

Conversion of derivative security

N/A

RXRX Chief Executive Officer Sep 6, 2024 04:57 PM Sale

$243.6K

RXRX Chief Executive Officer Aug 30, 2024 04:26 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 29, 2024 04:22 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 28, 2024 04:12 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 27, 2024 04:10 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 26, 2024 04:42 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 23, 2024 05:25 PM

Option Exercise

N/A

RXRX Chief Executive Officer Aug 19, 2024 07:09 PM

Option Exercise

N/A